Cerebral ischaemia - Hormone replacement therapy Factor
Definition
The RMA has defined hormone replacement therapy as the administration of oestrogen preparations often in combination with progesterone to offset a hormone deficiency following surgically induced or naturally occurring menopause.
General information
Treatment can be in the form of tablets or patches, and must be prescribed by a doctor. Such medications can consist of:
- oestrogen every day for 25 days per month, or continuous oestrogens given every day of the month, or
- oestrogens plus the addition of progesterone during the last 10 to 13 days of oestrogen therapy, or low dose continuous progesterone plus oestrogen daily.
Last reviewed for CCPS 24 May 2007.
Preliminary questions [37203]
37204 there is some evidence that hormone replacement therapy may be a factor in the development of the condition under consideration, a cerebrovascular accident.
1169 the veteran is a woman.
37202 the veteran was postmenopausal at the time of the clinical onset of cerebrovascular accident.
36719 the veteran has had hormone replacement therapy at some time.
37206 the veteran had hormone replacement therapy for treatment of an illness or injury which is identifiable.
37205 for treatment of the identified illness or injury, the veteran had hormone replacement therapy for a period of at least the 21 days before the clinical onset of the condition under consideration, a cerebrovascular accident.
37207 the veteran has established the causal connection between hormone replacement therapy and VEA service for the clinical onset of cerebrovascular accident.
37208 the veteran has established the causal connection between hormone replacement therapy and operational service for the clinical onset of cerebrovascular accident.
or
37209 the veteran has established the causal connection between hormone replacement therapy and eligible service for the clinical onset of cerebrovascular accident.
Clinical onset and operational service [37208]
37210 the identified illness or injury for which the veteran had hormone replacement therapy is causally related to operational service.
Clinical onset and eligible service [37209]
37211 the identified illness or injury for which the veteran had hormone replacement therapy is causally related to eligible service.